文献速递神经肿瘤

TTF-1:作为SEGA诊断标志物在免疫组化工具中的有利补充

TTF-1: A Well-Favored Addition to the Immunohistochemistry Armamentarium as a Diagnostic Marker of SEGA.
PubMed 文献 · World Neurosurg · 2021-12-03

研究在38例室管膜下巨细胞星形细胞瘤(SEGA)、30例中枢神经细胞瘤、各10例脑室内胶质母细胞瘤和室管膜瘤及5例皮质结节中行TTF-1免疫组化,并分析BRAFV600E突变。SEGA全部38例(100%)TTF-1阳性,其余肿瘤除2例神经细胞瘤(6.6%)外均阴性,SEGA均无BRAF免疫标记。

要点

  • 38例SEGA全部(100%)TTF-1免疫阳性,其中20例(52.6%)弥漫表达,18例(47.3%)局灶表达。
  • 除2例中枢神经细胞瘤(6.6%)外,室管膜瘤、胶质母细胞瘤和皮质结节均TTF-1阴性。
  • 所有SEGA病例均无BRAF免疫标记。

核心结论

  • SEGA中TTF-1表达与内侧神经节隆起发育中神经上皮细胞一致,提示在驱动因素存在下具有肿瘤潜能的祖细胞。

研究设计与样本

  • 在38例SEGA、30例中枢神经细胞瘤、各10例脑室内胶质母细胞瘤和室管膜瘤及5例皮质结节中,使用克隆8G7G3/1(1:50)行TTF-1免疫组化。
  • 使用Ventana免疫组化平台分析BRAFV600E突变。

主要发现

  • TTF-1免疫阳性见于全部38例(100%)SEGA,其中20例(52.6%)弥漫表达(>50%肿瘤面积),18例(47.3%)局灶表达(<50%)。
  • 所有病例均无BRAF免疫标记。
  • 除2例中枢神经细胞瘤(6.6%)外,室管膜瘤、胶质母细胞瘤和皮质结节均TTF-1免疫阴性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Subependymal giant cell astrocytoma (SEGA) is a World Health Organization grade 1 neoplasm, which, due to its dubious morphologic features, may be misdiagnosed as a high-grade tumor at times. This tumor shows binary immunoexpression including both glial and neural markers, leading to a state of diagnostic quandary. Recent evidences have surmised the diagnostic utility of thyroid transcription factor 1 (TTF-1), spurring us to study the practicality of this marker in distinguishing SEGAs from its mimics. METHODS: In this study, TTF-1 immunohistochemistry using clone 8G7G3/1 (1:50) was performed in 38 cases of SEGA, 30 cases of central neurocytoma, 10 cases each of intraventricular glioblastoma and ependymoma, and 5 cases of cortical tubers. Additionally, serine/threonine-protein kinase B-Raf (BRAFV600E) mutation, a common genetic alteration in pediatric low-grade-glial tumors with neuronal-differentiation, was analyzed using Ventana immunohistochemistry platform. RESULTS: TTF-1 immunopositivity was seen in all 38 cases (100%) of SEGAs, with 20 cases (52.6%) showing diffuse (>50% of tumor area) expression while focal (<50%) immunopositivity was seen in 18 cases (47.3%). None of the cases demonstrated serine/threonine-protein kinase B-Raf immunolabeling. Barring 2 cases of neurocytoma (6.6%), all other cases including ependymoma, glioblastoma, and cortical tubers were immunonegative for TTF-1. CONCLUSIONS: The congruous finding of TTF-1 expression in SEGA and cells of the developing neuroepithelium in the medial ganglionic eminence hint toward a primogenitor cell with neoplastic potential in the presence of impelling factors.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Dutta R, Sharma MC, Suri V, et al. TTF-1: A Well-Favored Addition to the Immunohistochemistry Armamentarium as a Diagnostic Marker of SEGA. World Neurosurg. 2021. PMID: 34871801. doi:10.1016/j.wneu.2021.11.125

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。